Is COVID-19 Friend or Foe to Industry 4.0: Experiences of Turkish White Goods Suppliers

被引:0
|
作者
Demirbag, Kubra Simsek [1 ]
Yildirim, Nihan [2 ]
机构
[1] Gumushane Univ, Management Informat Syst Dept, Gumushane, Turkey
[2] Istanbul Tech Univ, Management Engn Dept, Istanbul, Turkey
关键词
covid-19; fourth industrial revolution; industry; 4.0; pandemic; white goods;
D O I
10.1109/TEMSCONEUROPE54743.2022.9801958
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
This study, in the two years since the beginning of the COVID-19 pandemic, reveals the most focused issues by the Turkish white goods suppliers regarding Industry 4.0 and the challenges encountered while engaging in Industry 4.0 practices. The data were obtained through a questionnaire form participated by the managers of 36 different companies that are members of the Turkish White Goods Suppliers Association. The collected data were classified, and it was found that the most focused issues of the companies were technology investments, ERP and MES, data collection, business processes, investment plans, organizational transformation, occupational health and safety, and participation in Industry 4.0-related events, respectively. Moreover, the most common challenges companies face concerning Industry 4.0 are related to the not being able to come together, finance, technology providers, postponement of investment plans, and loss of employees. On the other hand, 16% of the participating companies stated that they did not encounter any difficulties.
引用
收藏
页码:67 / 72
页数:6
相关论文
共 50 条
  • [21] IL-33 in COVID-19: friend or foe?
    Yuejin Liang
    Yiyue Ge
    Jiaren Sun
    Cellular & Molecular Immunology, 2021, 18 : 1602 - 1604
  • [22] VITAMIN D SUPPLEMENTATION IN COVID-19: A FRIEND OR FOE?
    Mansour, Asieh
    Mohajeri-Tehrani, Mohammad Reza
    Sajjadi-Jazi, Sayed Mahmoud
    EXCLI JOURNAL, 2020, 19 : 1166 - 1168
  • [23] The role of ACEIs/ARBs in COVID-19: Friend or foe?
    Zhou, Zhe
    Qiu, Yumin
    Tao, Jun
    MEDICAL HYPOTHESES, 2020, 142
  • [24] Innate T cells in COVID-19: friend or foe?
    van der Heide V.
    Nature Reviews Immunology, 2020, 20 (7) : 407 - 407
  • [25] COVID-19 vaccines and blood glucose control: Friend or foe?
    Vena, Walter
    Pigni, Stella
    Betella, Nazarena
    Navarra, Annalisa
    Mirani, Marco
    Mazziotti, Gherardo
    Lania, Andrea G.
    Bossi, Antonio C.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [26] Getting the measure of the fourth industrial revolution: advantages and challenges of Industry 4.0 in the Turkish white goods industry
    Demirbag, Kubra Simsek
    Yildirim, Nihan
    CENTRAL EUROPEAN MANAGEMENT JOURNAL, 2023, 31 (01) : 82 - 101
  • [27] COVID-19 Drives Industry 4.0–and Reshoring
    Moser, Harry
    Manufacturing Engineering, 2021, 167 (03):
  • [28] IP-10 and complement activation as friend or foe in COVID-19
    Bunprakob, Saowalak
    Hemachudha, Pasin
    Ruchisrisarod, Chanida
    Supharatpariyakorn, Thirawat
    Hemachudha, Thiravat
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2022, 36
  • [29] Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?
    Sieiro Santos, Cristiana
    Casas Fernandez, Xenia
    Moriano Morales, Clara
    Diez Alvarez, Elvira
    Alvarez Castro, Carolina
    Lopez Robles, Alejandra
    Perez Sandoval, Trinidad
    RMD OPEN, 2021, 7 (01):
  • [30] Epistemic responsibilities in the COVID-19 pandemic: Is a digital infosphere a friend or a foe
    Curkovic, Marko
    Kosec, Andro
    Bedekovic, Marina Roje
    Bedekovic, Vladimir
    JOURNAL OF BIOMEDICAL INFORMATICS, 2021, 115